In fact, among Medicare beneficiaries aged 65 years or older, the incidence of transthyretin cardiac amyloidosis (ATTR-CM) diagnoses rose from about 10.1 per 100,000 person-years ...

March is recognized as Amyloidosis Awareness Month, yet for many in the Black community, this disease remains largely ...

A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...

The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

Please provide your email address to receive an email when new articles are posted on . Vutrisiran improved all-cause mortality and recurrent CV independent of disease severity in cardiac amyloidosis.

Research shows pTau levels in blood rise in systemic amyloidosis involving the heart and kidneys. The biomarker could aid earlier detection, clarify Alzheimer’s diagnosis, and help identify ...